Condition
Cervical Dystonia, Primary
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Terminated1
Not Yet Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03938363Not ApplicableCompletedPrimary
Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia
NCT06886750Phase 4Not Yet RecruitingPrimary
The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia
NCT02894359CompletedPrimary
Computer Modelling of the Cervical Spine Movements in Cervical Dystonia
NCT02837185Not ApplicableTerminatedPrimary
Effects of Botulinum Toxin on Muscle and Brain Activity
Showing all 4 trials